• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Sun Pharmaceuticals - Articles and news items

Lixiana

Merger between Daiichi Sankyo subsidiary Ranbaxy and Sun Pharma completed

Industry news / 25 March 2015 / Victoria White

Daiichi Sankyo have announced that the Sun Pharma and Ranbaxy merger process has been completed…

Daiichi Sankyo logo

Additional disclosure regarding the merger between Sun Pharma and Daiichi Sankyo’s subsidiary Ranbaxy

Industry news, News / 4 June 2014 / Daiichi Sankyo

As announced in releases dated April 7 and 11, 2014, Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has entered into agreements with Sun Pharmaceutical Industries Ltd. (“Sun Pharma”) in connection with merger of Ranbaxy Laboratories Limited (“Ranbaxy”) into Sun Pharma. Daiichi Sankyo hereby announces additional information regarding the details of this matter…

Novartis

Novartis settles patent litigation on Gleevec® (imatinib mesylate) with Sun Pharma subsidiary

Industry news / 15 May 2014 / Novartis

Novartis Pharmaceuticals Corporation has settled its litigation with the United States subsidiary of Sun Pharmaceutical Industries Ltd. relating to Novartis patents covering the use of certain polymorphic forms of Gleevec®…

Indian flag

Sun shines on Indian generics manufacturers

Industry news, News / 3 April 2013 / GlobalData

India is becoming a key market for generic medicines…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +